Biocon has posted a 72 per cent increase in net profit at Rs 206.3 crore during the quarter ended June 30, 2019, compared to Rs 119.7 crore registered during the same period of last year. The total income on a consolidated basis grew 25 per cent to Rs 1,490 crore during the quarter from Rs 1,192.6 crore a year ago, backed by the performance in biologics and small molecules business. Net profit, excluding exceptional item, stood at Rs 223 crore reporting growth of 86 per cent and it was impacted due to an exceptional item on account of tax on